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Abstract
Background: Loa loa has recently emerged as a filarial worm of significant public health importance as a
consequence of its impact on the African Programme for Onchocerciasis Control (APOC). Severe,
sometimes fatal, encephalopathic reactions to ivermectin (the drug of choice for onchocerciasis control)
have occurred in some individuals with high Loa loa microfilarial counts. Since high density of Loa loa
microfilariae is known to be associated with high prevalence rates, a distribution map of the latter may
determine areas where severe reactions might occur. The aim of the study was to identify variables which
were significantly associated with the presence of a Loa microfilaraemia in the subjects examined, and to
develop a spatial model predicting the prevalence of the Loa microfilaraemia.
Methods: Epidemiological data were collected from 14,225 individuals living in 94 villages in Cameroon,
and analysed in conjunction with environmental data. A series of logistic regression models (multivariate
analysis) was developed to describe variation in the prevalence of Loa loa microfilaraemia using individual
level co-variates (age, sex, µl of blood taken for examination) and village level environmental co-variates
(including altitude and satellite-derived vegetation indices).
Results: A spatial model of Loa loa prevalence was created within a geographical information system. The
model was then validated using an independent data set on Loa loa distribution. When considering both
data sets as a whole, and a prevalence threshold of 20%, the sensitivity and the specificity of the model
were 81.7 and 69.4%, respectively.
Conclusions: The model developed has proven very useful in defining the areas at risk of post-ivermectin
Loa-related severe adverse events. It is now routinely used by APOC when projects of community-
directed treatment with ivermectin are examined.
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Background
Knowledge of the spatial distribution of Loa loa is impor-
tant in countries involved in the African Programme for
Onchocerciasis Control (APOC) and is also now a signif-
icant issue for the Global Programme to Eliminate Lym-
phatic Filariasis (GPELF). Both programmes rely on the
wide-scale distribution of anti-helminthic drugs to poor
communities using community-directed drug distribu-
tion schemes. A problem was first observed in Cameroon
where a series of reports of severe and sometimes fatal
encephalopathic reactions to ivermectin (Mectizan®) in
individuals with high Loa loa microfilarial counts was
made [1-3]. Similar problems may occur when albenda-
zole (used to control lymphatic filariasis) is distributed in
Loa loa endemic areas although evidence for this is contra-
dictory [4-7].
Loa loa is associated with tropical "eye worm" (migration
of adult worms across the sub-conjunctiva), Calabar
swelling, oedemas and prurities but is not considered as
pathogenic as other filarial worms, and is consequently
less well studied. It is transmitted by species of horse-flies
(Chrysops spp.), most commonly Chrysops dimidiata and C.
silacea which inhabit the forest areas of West and Central
Africa, extending to the Ethiopian border. Severe and fatal
reactions to ivermectin have been associated with individ-
uals with high Loa loa microfilarial loads (more than
30,000 microfilariae (mfs) per ml of blood) and those
with more than 50,000 mfs/ml are considered at very high
risk [1,8-10].
Changes in the protocols for drug administration and
post-treatment surveillance in areas considered to be at-
risk of severe reactions to ivermectin have been imple-
mented [11,12], but the detailed geographic distribution
of Loa loa remains unclear [13]. Such information is essen-
tial in terms of developing safe treatment, and above all
surveillance strategies across the region and, given the vast
area which may be affected, it is recognized that rapid
assessment methods must be developed to evaluate the
risk of severe reactions in communities co-endemic for
loiasis and onchocerciasis.
Recent studies have shown that there is a close relation-
ship between intensity of microfilariae infection and prev-
alence rates of Loa loa [14,15] suggesting that a
distribution map based on prevalence of infection alone
(and not intensity, which would require time-consuming
counting of mfs) would provide sufficient information to
delineate areas of high risk of severe reactions. The aim of
our study was to develop a map indicating the areas where
Loa loa infection may be high enough (i.e. with a preva-
lence of Loa microfilaraemia in adults exceeding 20%)
that poses an operational problem for drug distribution
by the Community-Directed Treatment with Ivermectin
(CDTI) strategy [16].
As a preliminary step we created a risk model for Loa loa in
West and Central Africa based on the relationship of crude
Loa loa prevalence data (obtained from a literature search)
to a wide range of environmental variables. Initial results
suggested that land/forest cover derived from NOAA-
AVHRR satellite data (i.e. collected by the Advanced Very
High Resolution Radiometer on board the satellite series
operated by the National Ocean and Atmospheric Admin-
istration of the USA), and soil type (from the FAO digi-
tised soil map of Africa), are significant predictors and a
preliminary risk map was produced [17]. However, when
this first model was tested against field data from Cam-
eroon it was found to poorly represent areas of high risk
of infection in certain districts [18]. Possible reasons for
this include: (a) the low spatial resolution of the satellite
and environmental data used (1 km) which was unable to
identify narrow gallery forests in savannah areas and/or
(b) the use of prevalence data from various sources which
had not been standardised by age or sex.
In order to improve the quality of epidemiological data
being used to develop the model, we created a new preva-
lence database from a series of surveys conducted by the
team of the Institut de Recherche pour le Développement
(IRD) at the Centre Pasteur du Cameroun (CPC). A second
independent data set, collected as part of a project sup-
ported by the UNDP/World Bank/WHO Special Pro-
gramme for Research and Training in Tropical Diseases
(TDR) to calibrate a rapid clinical diagnosis of Loa loa
(RAPLOA) [15], was used to validate the results of the
model.
Methods
Epidemiological data
Epidemiological data used to create the model was
obtained from a series of field studies undertaken by the
IRD-CPC laboratory in Cameroon during the period
1991–2001 in which the presence of Loa loa parasites in
the blood of individuals was assessed. The data come
from five regions: (a) the forest-savannah mosaic area of
the Mbam and Kim division (Central province); (b) the
degraded forest area of the Lekie division (Central prov-
ince); (c) the dense forest area of the southern part of the
Central province; (d) the highland savannah area of the
Western Province; and (e) the savannah areas of the dis-
tricts of Banyo and Bankim, in the Adamaoua province.
The Ministry of Public Health of Cameroon provided eth-
ical approval for these surveys.
The total number of subjects included in the analysis was
14,225 individuals for 94 villages. Study participants con-
sisted of individuals over the age of 5 years who gave theirFilaria Journal 2004, 3:7 http://www.filariajournal.com/content/3/1/7
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consent or for whom consent was obtained from the par-
ent or guardian. Individuals who had had filaricidal
drugs, such as ivermectin or diethylcarbamazine, in the
previous five years were not included in the study. The
arrival of the research team in the villages was announced
to the population one week before the event through the
local authorities and teachers. The objective of the exami-
nations were clearly explained, and it was stated that each
individuals results would be returned. On the given day,
the team settled at a central place of the village (usually at
the chief's home, or in a school), and all the volunteers
were examined between 10.00 and 16.00 hours. A stand-
ardized quantity of capillary blood was obtained with a
non-heparinized micro-capillary tube. Prior to 1994, the
amount taken was 30 µl, and thereafter, 50 µl. After
Giemsa staining, the slides were examined under a micro-
scope and the presence of Loa mfs was recorded.
The latitude and longitude of all study villages were
obtained from either the ordinance survey map or a global
positioning system. Thus the data set included village
name, longitude and latitude, alongside data on individ-
uals examined (age, sex, standard size of blood sample
taken and presence/absence of Loa loa infection). A sum-
mary of the epidemiological data used is presented in
Table 1.
General principles of the analysis
The aim of the study was to identify variables which were
significantly associated with the presence of a Loa micro-
filaraemia in the subjects examined. Besides data on indi-
viduals (age, sex, size of blood sample), we investigated
whether some variables describing the environment of
their place of residence (see list of variables below) were
significantly related to the microfilaraemia. For these
environmental variables, distance operatives indicating
whether or not villages were within 5 km of potential at-
risk variables were created. Distance operatives were based
on the normal dispersal range of Chrysops which has been
shown to be within 5 km of their breeding sites [19].
In order to design a valid modelling structure, univariate
analysis was first undertaken of the relationship between,
on the one side, individual and environmental variables,
and on the other side the variable of interest, i.e. the pres-
ence/absence of Loa loa mfs in the individual. Then we
developed a series of logistic regression models (multivar-
iate analysis) to describe variation in the prevalence of Loa
loa microfilaraemia using individual level co-variates (age,
sex, µl of blood taken for examination) and village level
environmental co-variates. Logistic regression is useful to
predict the presence or absence of a characteristic or out-
come based on values of a set of predictor variables. It is
similar to a linear regression model but is suited to mod-
els where the dependent variable is dichotomous. Logistic
regression coefficients can be used to estimate odds ratios
for each of the independent variables in the model. In our
example the dichotomous variable is the presence or
absence of Loa loa infection in each individual in the sam-
ple. Those variables which did not have a significant rela-
tionship with age and sex adjusted prevalence were
excluded from further analysis. All variables were ana-
lysed at individual level.
Environmental variables and data sets included in the 
analysis
The distribution of the human population in sub-Saharan
Africa is relatively well described from population census
Table 1: Epidemiological data sets used in development of the spatial model for predicting the prevalence of Loa microfilaraemia
Region Sex* Blood sample 
(µl)
Prevalence of 
Loa loa
Age range No. subjects No. villages
Banyo-Bankim M 50.00 22.21 5–98 1783 16
Banyo-Bankim F 50.00 20.00 5–90 1815
South of Central Province M 30.00 32.81 5–80 381 5
South of Central Province F 30.00 27.37 5–80 453
South of Central Province M 50.00 24.76 5–86 941 17
South of Central Province F 50.00 18.49 5–90 1206
Lekie Department M 30.00 26.33 5–91 1052 14
Lekie Department F 30.00 19.10 5–92 1340
Lekie Department M 50.00 23.96 5–80 359 3
Lekie Department F 50.00 21.41 5–90 369
Mbam et Kim M 30.00 12.37 5–99 1293 24
Mbam et Kim F 30.00 4.53 5–95 1281
Western Province M 50.00 6.22 15–99 916 15
Western Province F 50.00 3.76 15–99 1036
* M = male and F = femaleFilaria Journal 2004, 3:7 http://www.filariajournal.com/content/3/1/7
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data obtained at the national and sub-national level. The
population data for 1990 used in this analysis was
obtained from the Global Resource Information Database
of the United Nations Environment Programme (UNEP-
GRID), Eros Data Centre [20]. These population density
surfaces (with 1 km resolution) have been derived from a
model including population estimation for countries,
population of major urban centres and transportation
network and accessibility. They have been used in numer-
ous studies involving population distribution in Africa,
including studies on estimating the burden of malaria
[21].
The USGS (United States Geological Survey) hydrologic
digital dataset provides detailed descriptions of the topog-
raphy of the area, including elevation (Digital Elevation
Model, DEM), slope, aspect (direction of maximum rate
of change in elevation between each cell and its eight
neighbours and representing direction of slope), flow
accumulation (defining amount of upstream area drain-
ing into each cell) [22].
Satellite data indicating the 'greenness' of the environ-
ment (Normalised Difference Vegetation Index, NDVI)
was obtained from the VEGETATION sensor launched in
1998 onboard the SPOT 4 satellite system. NDVI images
have been specifically tailored to monitor global land sur-
faces' parameters on a daily basis with a medium spatial
resolution of one km [23]. They permit monitoring of sea-
sonal and inter-annual variation in vegetation status and
have been shown elsewhere to be important correlates of
the spatial and temporal changes in the distribution of
insect vectors of disease [24]. Free access is given to 10
daily synthesized maximum value composite products 3
months after insertion in the VEGETATION archive [25].
Thirty-six decadal NDVI images were obtained from SPOT
VEGETATION satellite sensor data archive for 1999. The
VEGETATION data used consists of 10 daily NDVI prod-
ucts, compiled from daily synthesis over the previous ten
days, for the entire African continent, to which both radi-
ometric corrections and geometric corrections have been
applied to enhance product quality. The true value of
NDVI was calculated from the 8 bit decadal images (1–
255) using ((digital number*0.004)-0.1). From the true
values images, mean, minimum, maximum, median,
standard deviation were calculated for the year 1999.
In order to take into account the flight distance of the vec-
tor, 5 km buffers were created around each study village
and the mean value of the NDVI variable was obtained and
used in the development of the logistic regression model.
Validation of the model
Epidemiological data used to validate the model was
obtained from a multicentric study supported by TDR
which was designed to assess the relationship between
clinical and parasitological indicators of Loa loa endemic-
ity [15,26]. The surveys were conducted by three research
teams (comprising epidemiologists, parasitologists, social
scientists and clinicians) based in Buea and Yaoundé,
both in Cameroon, and in Calabar, Nigeria. Only data
from Cameroon are used in our validation process. The
Buea study sites were in South-West and North-West Prov-
inces of Cameroon; in these areas, a total of 4532 individ-
uals over the age of 15 years, living in 42 villages,
participated in the survey. The study sites for the Yaoundé
team were located in the East Province of Cameroon,
where 3181 persons of the same age, living in 32 locali-
ties, were examined. A standardized questionnaire was
administered to participants from whom finger-prick
blood samples were collected and examined for Loa loa
mfs. Model validation was undertaken through correlat-
ing model outputs with the independent data set.
Results
Univariate analysis
While Loa loa prevalence when regressed against popula-
tion density was not found to be significantly correlated,
a strong and significant linear relationship (r2 = 0.7699; P
< 0.001) was found with age below 40 years (Figure 1). In
our analysis we used this linear relationship for all indi-
viduals below 40 but then treated all those above 40 as
though they remained at this age since any subsequent
change with age was deemed non-significant. This broken
stick approach was considered to be a reasonable strategy
and much simpler than fitting a non-linear model.
Prevalence rates were significantly (P < 0.001) higher in
males than in females (19.8% n = 6725 and 15.2% n =
7500 respectively). Sex was therefore entered (as a cate-
gorical variable) in the logistic regression model.
As one would expect, prevalence rates were significantly
higher (P < 0.001) in individuals from whom the blood
smear was prepared using a volume of 50 µl as compared
with those from whom 30 µl of blood were taken. Blood
sample size was therefore entered (as a categorical varia-
ble) in the logistic regression model.
After investigating the value of the DEM and its associated
files (slope, aspect, flow accumulation) in predicting
microfilaraemia prevalence using univariate and multi-
variate regression statistics, the DEM alone was chosen as
a predictive variable for the development of a logistic
regression model. Because the relationship between Loa
loa prevalence and the DEM was found to be non-linear
(Figure 2) the DEM data was divided up into 250 m inter-
val classes and treated as a categorical variable.Filaria Journal 2004, 3:7 http://www.filariajournal.com/content/3/1/7
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Since univariate analysis of the SPOT VEGETATION NDVI
data against prevalence indicated a non-linear relation-
ship [Figure 3a and 3b], the satellite data were entered
into the model as a series of numeric variables (the origi-
nal, the square and the cube) for the mean, the minimum,
the maximum and the standard deviation. Standard devi-
ation and maximum NDVI were most strongly correlated
with prevalence using univariate analysis.
Multivariate analysis
Separate and combined models were created which
included all individual level co-variates and altitude for
both buffered and non-buffered SPOT VEGETATION data
variables. Final model choice was based on (a) the sim-
plicity and biological validity of the model (b) the predic-
tive capacity of the model when assessed using bootstrap
methodology (where half of the data was extracted
randomly from the data set and tested against model
results developed from the remaining half) and (c) the
ability of the model to be extended over the large geo-
graphic area involved in the APOC programme.
Thus, besides the three individual-level covariates (sex,
age and blood sample size), only three village level envi-
ronmental co-variates were kept in our model: maximum
annual NDVI, standard deviation of the NDVI, and eleva-
Relationship between prevalence of Loa loa microfilaraemia and age Figure 1
Relationship between prevalence of Loa loa microfilaraemia and age.
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tion. In the final model, the probability of a female indi-
vidual being infected with Loa loa is represented by:
1/(1+e-z), where (for our example a female aged ≥ 40
years, and a blood sample of 50 µl):
[Z] = ([Sex]*0.221)
+ ([Age] * 0.049)
- ([Blood sample size]*0.542)
+ ([Maximum NDVI2] * 74.38)
- ([Maximum NDVI3] * 58.816)
+ ([Standard deviation NDVI] * 11.788)
+ (([Elevation] < 250) * 1.133)
+ (([Elevation] = 250-500) * 0.865)
+ (([Elevation] = 500-750) * 0.981)
+ (([Elevation] = 750-1000) * 1.171)
- (([Elevation] = 1000-1250) * 0.623)
- (([Elevation] = 1250-1500) * 1.516)
- (([Elevation] = 1500-1750) * 1.342)
Relationship between prevalence of Loa loa microfilaraemia and elevation Figure 2
Relationship between prevalence of Loa loa microfilaraemia and elevation.
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Relationship between prevalence of Loa loa microfilaraemia and standard deviation of NDVI (a); and between prevalence of Loa  loa microfilaraemia and maximum annual NDVI (b) Figure 3
Relationship between prevalence of Loa loa microfilaraemia and standard deviation of NDVI (a); and between prevalence of Loa 
loa microfilaraemia and maximum annual NDVI (b).
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- (([Elevation] = 1750-2000) * 0.669)
- 22.883 (constant),
where [Sex] = 0 for females, and 1 for males; and [Blood
sample size] = 0 for 30 µl, and 1 for 50 µl.
Thus for our example, age, sex and blood sample size var-
iables are presented for a fixed value because of their non-
spatial nature. The probability of infection increases (+)
with increasing value for sex (0 versus 1), with increasing
age, and with increasing standard deviation of NDVI and
Maximum NDVI2; it decreases (-) with Maximum NDVI3
(indicating that the relationship to maximum NDVI is
non linear), and increases for categories of elevation
between 0 and 1000 metres after which it decreases. The
probability of infection decreases with increasing value of
blood sample size (0 versus 1) even if larger blood sample
should normally allow better detection of the infection.
This could be due to the fact that larger samples have been
taken often in places where infection rates are low, in the
highlands, and this is presumably a result of interacting
with the other variables.
A similar model can be made for males and individuals at
any other age. The model was developed using 50% of the
data (randomly selected) and then tested on the remain-
ing 50% of the data. When the model results were plotted
against the observed data an r2 of 0.6033 was obtained
(Figure 4). In addition, when one takes the threshold of
20% as the Loa microfilaraemia above which there is a risk
of post-ivermectin encephalopathy, the sensitivity and
specificity of the model (respectively: the proportion of
villages with a measured prevalence ≥ 20%, and which
were correctly predicted as such by the model; and the
proportion of villages with a measured prevalence <20%,
and correctly identified as such by the model) were found
to be 77.1 and 80.0%, respectively (Table 2).
Mapping the model results: an Environmental Risk Map 
for Loa loa
In order to standardize the variables relating to individu-
als (which cannot be mapped) we chose values that best
represent the average adult population (above the age of
15) i.e. 50:50 male – female ratio, age 40 and a blood
sample of 50 µl. Age 32 was the approximate average age
of individuals in the data sets used to develop the model.
Using age 40 (the average age of individuals >15 years of
age) in the model was therefore likely to slightly over-rep-
resent infection in these data sets but the final model
would be directly comparable with current policy to
exclude individuals below the age of 15 from rapid epide-
miological surveys for loiasis [14,15]. In order to create a
model, which included both males and females, two sep-
arate models were created, one for each sex and the mean
of the two model results taken.
Validation of the model
Since the chosen model was based on environmental var-
iables, which could be mapped across the entire country,
it was possible to extrapolate the model results to the
whole of Cameroon (Figure 5) and compare them with
the results of the independent TDR survey. Correspond-
ence between observed prevalence from the TDR verifica-
tion data set and the model results was found to be very
close: the sensitivity and the specificity of the model,
when using the prevalence threshold of 20%, were 86.1
and 52.6%, respectively. Five villages were observed to
have high prevalence rates (>20%) despite being model
predictions for prevalence below 20% (Table 2). Two vil-
lages, Nguri and Ngu, located in the North-West province,
were classified as extremes (Figure 6). Inaccuracies in the
georeferencing of the village location or the spatial data
used to create the model may account for this, as could the
possibility that the local population regularly visit the
Chrysops  infested area nearby. The three other villages
(Ntem, Boum and Baktala) are all villages from the East-
ern Province of Cameroon which were sited on very local-
ised areas where model predictions for <20% prevalence
occurred. These villages were all within 1 km of areas
where model results predicted >20% prevalence.
When one considers both datasets as a whole, and the
prevalence threshold of 20%, the sensitivity and the spe-
cificity of the model were 81.7 and 69.4%, respectively.
Discussion
Detailed information on distribution of disease and levels
of endemicity is a prerequisite for effective planning of
control programmes. This has been an important element
in the planning of the African Programme for Onchocer-
ciasis Control (APOC) where community-directed treat-
ment with ivermectin (Mectizan®) has been targeted at
areas of hyper- and meso-endemicity, identified by Rapid
Epidemiological Mapping [27]. The expansion of the
APOC programme in Cameroon has been delayed due to
severe (sometimes fatal) adverse reactions in patients
receiving ivermectin who were co-infected with Loa loa.
This has led to caution in defining new areas for the
expansion of the programme and a requirement for iden-
tifying areas of high risk of Loa loa using a potentially
rapid and extensive methodology. Thomson et al. [17]
developed a preliminary model using satellite mapping
based on existing knowledge of distribution and preva-
lence, and recently a method of rapid assessment using a
simple questionnaire, called RAPLOA, has been devel-
oped [15].Filaria Journal 2004, 3:7 http://www.filariajournal.com/content/3/1/7
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Relationship between observed prevalence of Loa loa microfilaraemia and predicted prevalence Figure 4
Relationship between observed prevalence of Loa loa microfilaraemia and predicted prevalence.
Table 2: Distribution of the villages examined, according to their observed and predicted prevalence of Loa microfilaraemia
Observed prevalence
<20% ≥ 20%
Predicted prevalence First dataset <20% 48 8
(collected by IRD-CPC) ≥ 20% 12 27
Dataset used for validation <20% 20 5
(collected by TDR) ≥ 20% 18 31
Predicted prevalence of Loa loa
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This paper further develops the satellite-derived risk map
of  Loa loa by using improved satellite data sets and
detailed information on infection rates in villages in
various ecological zones in Cameroon. The resulting
model is able to predict prevalence risk throughout south-
ern Cameroon with a greater accuracy than hitherto avail-
able. The final model has been chosen because of the
good fit between observed and predicted prevalence and
is based on elevation and 1 km SPOT VEGETATION data.
In order to understand the value of the risk map it is
important to note that (a) while the 1 km resolution of
the environmental data cannot reveal the small and local-
ised muddy breeding sites of the Chrysops vectors, their
general habitat is well captured by the model and it is rec-
ognised that the 1 km resolution is much less than the dis-
persal capacities of the adult flies; and (b) the model is not
dependant on the seasonal or inter-annual variability of
the vector density, since this is not reflected in fluctuations
in Loa microfilaraemias, because the adult worm life-span
is much longer (4–17 years).
Among the areas in which the prevalences of Loa loa are
particularly high, according to the Environmental Risk
Map (ERM), two should be pointed out, because they are
also those where most of the cases of serious adverse
events (SAEs) have been recorded so far. The first one is
the Lekie Department (Central Province), in the Sanaga
valley, where 53 of the 63 probable or possible Loa loa
encephalopathy cases recorded between 1989 and 2001
in Cameroon have occurred [3]. Besides the high level of
endemicity, this cluster of cases may be related to the high
population density there, as well as the proximity of the
area with the capital, Yaoundé, which probably led to a
high reporting rate; however, other hypothesis should be
considered, such as specific susceptibility of the local
human populations, or special pathogenicity of the local
Loa  "strain" [28,29]. The latter possibility is currently
investigated in Cameroon, and in the Mayumbe forest
(Democratic Republic of Congo), another area where
some 15 cases of fatal SAEs were reported in December
2003. The second area of interest shown by the ERM in
Cameroon is the Tikar plain, near Bankim, between the
Western, North-West and Adamaoua provinces, where
Predictive model of Loa loa prevalence for Cameroon overlaid with the observed prevalence data Figure 5
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several cases have been recently reported, though the
area's vegetation is of shrub savanna type. The ERM also
shows those areas where CDTI projects against onchocer-
ciasis may be implemented in a near future, and where the
risk of SAEs is probably high: the Eastern and Southern
Provinces, and the north-western part of the Littoral
Province.
While the use of satellite-derived environmental data for
evaluation of disease risk has been developed for several
vector borne diseases (malaria, Rift Valley fever, visceral
leishmaniasis, tick-borne encephalitis) [24], limited use
of such data in public health programmes for the control
of infectious diseases has been achieved.
This paper defines a model which identifies areas of
potential high risk of severe adverse reactions to ivermec-
tin, and will contribute to APOC's programme develop-
ment by enabling resources to be effectively targeted to
areas deemed at risk. The Technical Consultative Commit-
tee of APOC, and the Mectizan Expert Committee have
developed a series of recommendations aimed at "facili-
tating effective detection and management of SAEs fol-
lowing treatment with Mectizan in known and suspected
Loa loa endemic areas". Three types of mass treatment
strategies have been defined, according to the levels of
endemicity of onchocerciasis and of loiasis, the latter
being defined by the prevalence of Loa microfilariae (<20
% versus ≥ 20%) or of history of eye worm passage (<40
% versus ≥ 40%). In those areas where onchocerciasis is
meso- or hyperendemic, and the prevalence of Loa mfs
exceeds 20%, a number of detailed measures should be
taken, regarding training of community distributors and
medical personnel, availability of medical supplies, dura-
tion of distribution, surveillance of the treated popula-
tions, and management of the patients who develop a
SAE. Though lower, the risk that SAE occur in areas where
the prevalence of Loa microfilaraemia is lower than 20%
is not nil, and thus guidelines have also been developed
regarding the strategy to apply in such situations [30].
The model developed is by no means a definitive product
but provides a basis for decision making in terms of where
rapid epidemiological surveys for loiasis should now be
targeted. Modelling in this way permits an iterative
process between field epidemiologist and modeller which
Inset of verification villages in North-West province of Cameroon (note the position of Nguri and Ngu) Figure 6
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not only means that decisions are made on the best avail-
able data but that such data is updated rapidly as new sur-
vey results are entered in the database and the model
refined. Models are valuable in so far as they reflect reality.
Given the complexity of disease transmission processes
where human, parasite, vector and environment interact,
it is impossible to think that all relevant factors can be
incorporated into a general model which can be applied
on a regional scale. What is significant here is the fact that
important decisions need to be made now with regard to
the likely spatial extent of the distribution of Loa loa. As it
stands, the model presented here uses environmental fea-
tures known to be associated with the biology of the vec-
tor, is robust for the area of data collection and predicts
areas within Cameroon where Loa loa has been found in
the past. It provides a rapid assessment methodology of
areas where adverse reactions to ivermectin may occur and
will be further developed in conjunction with the
RAPLOA procedure which APOC intends to apply to
CDTI areas potentially endemic for Loa loa [15]. The next
step in the process will be to update the model with new
data (e.g. the verification data set) from all the countries
where loiasis is endemic, and to explicitly represent
uncertainty in the model outputs so that decision makers
will be able to assess for themselves the quality of the
model results for their area of interest.
List of abbreviations
APOC African Programme for Onchocerciasis Control
CDTI Community-Directed Treatment with Ivermectin
CPC Centre Pasteur du Cameroun
DEM Digital Elevation Model
ERM Environmental Risk Map for Loa loa
GIS Geographic Information System
GPELF Global Programme to Eliminate Lymphatic
Filariasis
IRD Institut de Recherche pour le Développement
Mfs Microfilariae
NDVI Normalised Difference Vegetation Index
NOAA-AVHRR National Ocean and Atmospheric Admin-
istration – Advanced Very High Resolution Radiometer
RAPLOA Rapid Assessment of the Prevalence and Inten-
sity of Loa infection
SAE Serious Adverse Event
SPOT Satellite Pour l'Observation de la Terre
TDR UNICEF/UNDP/World Bank/WHO Special Pro-
gramme for Research and Training in Tropical Diseases
UNEP-GRID United Nations Environment Programme-
Global Resource Information Database
USGS United States Geological Survey
Competing interests
None declared.
Authors' contribution
MCT designed the study, planned the analysis, supervised
the modelling, interpreted the results, and wrote the
paper.
VO prepared the data, developed the model, prepared the
maps, and wrote the paper.
JK and JG collected the field data used for the develop-
ment of the model.
SW, IT and PE collected the field data used for the valida-
tion of the model.
JHR supervised the study thanks to which the validation
data were collected.
DHM proposed the study, contributed to its design and
interpretation of the results.
MB designed the study, planned the analysis, collected the
field data, interpreted the results, and wrote the paper.
Acknowledgements
Mark Cresswell and Tudor Davies are acknowledged for assistance in data 
processing. This work was undertaken with financial support from The Afri-
can Programme for Onchocerciasis Control (TSA 08/181/451/AP/98 and 
08/181/502/AP/99). Dr. A. Sékétéli, Director of APOC, and Dr. M. Noma, 
Chief of the Epidemiology and Vector eradication Unit of APOC, are 
thanked for their encouragement and support. The independent data that 
were used for validation of the model was collected with financial support 
from the UNICEF/UNDP/World Bank/WHO Special Programme for 
Research and Training in Tropical Diseases (TDR).
References
1. Gardon J, Gardon-Wendel N, Demanga-Ngangue , Kamgno J, Chip-
paux JP, Boussinesq M: Serious reactions after mass treatment
of onchocerciasis with ivermectin in an area endemic for Loa
loa infection. Lancet 1997, 350:18-22.
2. Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P,
Chippaux JP: Three probable cases of Loa loa encephalopathy
following ivermectin treatment for onchocerciasis. Am J Trop
Med Hyg 1998, 58:461-469.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Filaria Journal 2004, 3:7 http://www.filariajournal.com/content/3/1/7
Page 13 of 13
(page number not for citation purposes)
3. Twum-Danso NA: Serious adverse events following treatment
with ivermectin for onchocerciasis control: a review of
reported cases. Filaria J 2003, 2(Suppl 1):S3.
4. Klion AD, Massougbodji A, Horton J, Ekoué S, Lanmasso T, Ahouis-
sou NL, Nutman TB: Albendazole in human loiasis: results of a
double-blind, placebo-controlled trial.  J Infect Dis 1993,
168:202-206.
5. Blum J, Wiestner A, Fuhr P, Hatz C: Encephalopathy following
Loa loa treatment with albendazole. Acta Trop 2001, 78:63-65.
6. Kamgno J, Boussinesq M: Effect of a single dose (600 mg) of
albendazole on Loa loa microfilaraemia. Parasite 2002, 9:59-63.
7. Tsague-Dongmo L, Kamgno J, Pion SDS, Moyou-Somo R, Boussinesq
M: Effects of a 3-day regimen of albendazole (800 mg daily)
on  Loa loa microfilaraemia.  Ann Trop Med Parasitol 2002,
96:707-715.
8. Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC:
Severe adverse reaction risks during mass treatment with
ivermectin in loiasis-endemic areas.  Parasitol Today 1996,
12:448-450.
9. Boussinesq M, Gardon J: Challenges for the future: loiasis. Ann
Trop Med Parasitol 1998, 92(Suppl 1):S147-S151.
10. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP: Clinical
picture, epidemiology and outcome of Loa-associated seri-
ous adverse events related to mass ivermectin treatment of
onchocerciasis in Cameroon. Filaria J 2003, 2(Suppl 1):S4.
11. Anonymous: Treating onchocerciasis in loiasis endemic areas.
Mectizan Programe Notes 2000, 25:1-2.
12. Haselow NJ, Akame J, Evini C, Akongo S: Programmatic and com-
munication issues in relation to serious adverse events fol-
lowing ivermectin treatment in areas co-endemic for
onchocerciasis and loiasis. Filaria J 2003, 2(Suppl 1):S10.
13. Boussinesq M, Gardon J: Prevalences of Loa loa microfilaraemia
throughout the area endemic for the infection. Ann Trop Med
Parasitol 1997, 91:573-589.
14. Boussinesq M, Gardon J, Kamgno J, Pion SDS, Gardon-Wendel N,
Chippaux JP: Relationships between the prevalence and inten-
sity of Loa loa infection in the Central province of Cameroon.
Ann Trop Med Parasitol 2001, 95:495-507.
15. Takougang I, Meremikwu M, Wanji S, Yenshu EV, Aripko B, Lamlenn
SB, Braide LE, Enyong P, Meli J, Kale O, Remme JH: Rapid assess-
ment method for prevalence and intensity of Loa loa infec-
tion. Bull World Health Organ 2002, 80:852-858.
1 6 . O b s o m e r  V ,  B o u s s i n e s q  M ,  K a m g n o  J ,  M a y a u x  P ,  C o n n o r  S J ,
Molyneux DH, Thomson MC: Use of geographical information
systems and remote sensing technologies in the mapping of
Loa loa. Trans R Soc Trop Med Hyg 2002, 96:364.
17. Thomson MC, Obsomer V, Dunne M, Connor SJ, Molyneux DH: Sat-
ellite mapping of Loa loa prevalence in relation to ivermectin
use in west and central Africa. Lancet 2000, 356:1077-1078.
18. Kamgno J, Boussinesq M: Hyperendémicité de la loase dans la
plaine Tikar, région de savane arbustive du Cameroun. Bull
Soc Pathol Exot 2001, 94:342-346.
19. Chippaux JP, Bouchité B, Demanou M, Morlais I, Le Goff G: Density
and dispersal of the loaiasis vector Chrysops dimidiata in
southern Cameroon. Med Vet Entomol 2000, 14:339-344.
20. UNEP/GRID – Sioux Falls  [http://grid2.cr.usgs.gov/]
21. Snow RW, Craig M, Deichmann U, Marsh K: Estimating mortality,
morbidity and disability due to malaria among Africa's non-
pregnant population. Bull World Health Organ 1999, 77:624-640.
22. Hydro 1K Africa  [http://edcdaac.usgs.gov/gtopo30/hydro/
africa.html]
23. Spotimage  [http://www.spotimage.fr/]
24. Thomson MC, Connor SJ: Environmental information systems
for the control of arthropod vectors of disease.  Med Vet
Entomol 2000, 14:227-244.
25. Free vegetation products  [http://free.vgt.vito.be/]
26. Wanji S, Tendongfor N, Esum M, Ndindeng Atanga S, Enyong P: Het-
erogeneity in the prevalence and intensity of loiasis in five
contrasting bioecological zones in Cameroon. Trans R Soc Trop
Med Hyg 2003, 97:183-187.
27. Ngoumou P, Walsh JF, Macé JM: A rapid mapping technique for
the prevalence and distribution of onchocerciasis: a Cam-
eroon case study. Ann Trop Med Parasitol 1994, 88:463-474.
28. Duke BOL: Overview: Report of a scientific working group on
serious adverse events following Mectizan treatment of
onchocerciasis in Loa loa endemic areas. Filaria J 2003, 2(Suppl
1):S1.
29. Higazi TB, Klion AD, Boussinesq M, Unnasch TR: Genetic hetero-
geneity in Loa loa parasites from southern Cameroon: a pre-
liminary study. Filaria J 2004, 3:4.
30. The Mectizan® Expert Committee and the Technical Consultative
Committee:  Recommandations for the treatment of
onchocerciasis with Mectizan®  in areas co-endemic for
onchocerciasis and loiasis.  [http://mectizan.org/library/English
MECTCCLoaRecs-June04.pdf].